Papers: 10.1371/journal.pone.0158526

https://doi.org/10.1371/journal.pone.0158526

An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1)

Cited by: 3
Author(s): Tarik Asselah, Christophe Moreno, Christoph Sarrazin, Michael Gschwantler, Graham R. Foster, Antonio Craxı̀, Peter Buggisch, Robert J. Ryan, Oliver Lenz, Jane Scott, G. Van Dooren, Isabelle Lonjon–Domanec, Michael Schlag, Marı́a Buti
Published: about 10 years ago

Software Mentions 1